BeiGene Blocks US Rival To Brukinsa Blockbuster Until 2037

MSN Agrees Settlement Allowing Zanubrutinib Launch In 13 Years

 
• By Dave Wallace
  
MSN can launch its US zanubrutinib generic in 2037 (Shutterstock)

More from Generics

More from Business